Gates and WHO Partner to Create the Global Vaccine Action Plan

Gates and WHO Partner to Create the Global Vaccine Action Plan










The World Health Organization (WHO) has devised a scheme to vaccinate people living in over 194 countries. They joined forces with the Decade of Vaccine Collaboration (DVC) and published their plan last month.

The Global Vaccine Action Plan (GVAP)
is pushing governments worldwide with the power of the UN to back them
to coerce the increase of global vaccinations through strategic
programs.

The DVC is comprised of stakeholders from the global health community.
The Bill and Melinda Gates Foundation (BMGF) have also partnered with
the WHO and DVC to support GVAP.

The BMGF released a statement on
the GVAP saying that they are excited to be part of this “incredible
opportunity” to continue their efforts to eradicate polio in “Nigeria,
Pakistan, and Afghanistan” and fund “vaccination campaigns with the
support of international partners.

The details of GVAP include
delivery of vaccines to DVC between 2011 – 2020 with aims to administer
these immunizations to underdeveloped nations like Africa and India.
The initiative will attempt to exceed the UN’s Millennium Development Goal (MDG)
that “immunization . . . should be recognized as a core component of
the human right to health”, the plan says. The plan’s mission is to
“extend, by 2020 and beyond, the full benefit of immunization to all
people.”


Strategic objectives of the scheme are defined:

• Extending the polio vaccine program to global expectations
  
• Meeting regional elimination targets through immunizations
  
• Meeting vaccination targets in every region, community and country
  
• Collaborating with drug corporations to produce vaccines and technologies
  

WHO and DVC want to build relationships with pharmaceutical
manufacturers to research and develop new vaccines for diseases that are
not treatable through immunization.

By 2015, all underdeveloped nations will be admonished by the UN to
introduce one or more underutilized vaccines, which will be licensed and
disbursed by WHO and DVC to low- or middle-income countries by 2020.

Misleading statistics are being purveyed as empirical data that give
unfounded explanations and rhetoric over routine vaccination and new
vaccine development. WHO is depending on vaccination surveys (which are
inherently flawed) to rationalize their claim that 82% of the poorest
countries need to have DTP3 administered which encompasses the majority
of the population.

WHO and the UN decide amongst world leaders as to which nations will be
the focus of vaccinations. These nations are Africa, India and some
parts of Asia, where the UN has identified the population growth to be
expanding too quickly.

Daniel Berman, deputy director of the Campaign for Access to Essential Medicines at
the Médecins Sans Frontières, in Switzerland, said that the plan
focuses primarily on new vaccines, when he feels that routine
vaccination is a more effective course of action.

Berman believes vaccines administered by inhalation, skin patches or
orally can improve the immunization coverage. While new storage
procedures may alleviate the need for cold storage, less logistical
“challenges” will be placed on healthcare workers.

Berman added that local production of vaccines could have a “positive
effect on emerging, middle-income countries” as well as lower the cost
of vaccine technologies.

Through corporatism, pharmaceutical corporations could relocate
facilities to Africa and India for technology production and transfer,
as well as give access to licenses.

Simon Wright, director of Child Survival at Save the Children UK is
pleased with the plan by WHO and DVC. Wright says that this initiative
will provide a “strong focus on building health systems to reach those
children who were still not vaccinated.”


Source:-
http://www.activistpost.com/2012/06/gates-and-who-partner-to-create-global.html